Literature DB >> 26756662

Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Maxime Donadieu1,2, Yann Le Fur1,2, Angèle Lecocq1,2, Andrew A Maudsley3, Soraya Gherib1,2,4, Elisabeth Soulier1,2, Sylviane Confort-Gouny1,2, Fanelly Pariollaud1,2,4, Marie-Pierre Ranjeva1,2,4, Jean Pelletier1,4, Maxime Guye1,2, Wafaa Zaaraoui1,2, Bertrand Audoin1,4, Jean-Philippe Ranjeva1.   

Abstract

PURPOSE: To detect local metabolic abnormalities over the complete human brain in multiple sclerosis (MS) patients, we used optimized fast volumic echo planar spectroscopic imaging (3D-EPSI).
MATERIALS AND METHODS: Weighted mean combination of two 3D-EPSI covering the whole brain acquired at 3T in AC-PC and AC-PC+15° axial planes was performed to obtain high-quality metabolite maps for five metabolites: N-acetyl aspartate (NAA), glutamate+glutamine (Glx), choline (Cho), myo-inositol (m-Ins), and creatine+phosphocreatine (tCr). After spatial normalization, maps from 19 patients suffering from relapsing-remitting MS were compared to 19 matched controls using statistical mapping analyses to determine the topography of metabolic abnormalities. Probabilistic white matter (WM) T2 lesion maps and gray matter (GM) atrophy maps were also generated.
RESULTS: Two-group analysis of variance (ANOVA) (SPM8, P < 0.005, false discovery rate [FDR]-corrected P < 0.05 at the cluster level with age and sex as confounding covariates) comparing patients and controls matched for age and sex showed clusters of abnormal metabolite levels with 1) decreased NAA (around -15%) and Glx (around 20%) predominantly in GM within prefrontal cortices, motor cortices, bilateral thalami, and mesial temporal cortices in line with neuronal/neuro-astrocytic dysfunction; 2) increased m-Ins (around + 20%) inside WM T2 lesions and in the normal-appearing WM of temporal-occipital lobes, suggesting glial activation.
CONCLUSION: We demonstrate the ability to noninvasively map over the complete brain-from vertex to cerebellum-with a validated sequence, the metabolic abnormalities associated with MS, for characterizing the topography of pathological processes affecting widespread areas of WM and GM and its functional impact. J. Magn. Reson. Imaging 2016;44:411-419.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  inflammation; multiple sclerosis; neurodegeneration; proton magnetic resonance spectroscopic imaging; statistical mapping analysis; whole brain

Mesh:

Substances:

Year:  2016        PMID: 26756662      PMCID: PMC4940345          DOI: 10.1002/jmri.25139

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  40 in total

1.  Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis.

Authors:  A Ebel; B J Soher; A A Maudsley
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

2.  Total brain N-acetylaspartate: a new measure of disease load in MS.

Authors:  O Gonen; I Catalaa; J S Babb; Y Ge; L J Mannon; D L Kolson; R I Grossman
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 3.  Brain proton magnetic resonance spectroscopy: introduction and overview.

Authors:  Débora Bertholdo; Arvemas Watcharakorn; Mauricio Castillo
Journal:  Neuroimaging Clin N Am       Date:  2013-01-20       Impact factor: 2.264

4.  Statistical mapping of metabolites in the medial wall of the brain: a proton echo planar spectroscopic imaging study.

Authors:  David M Niddam; Shang-Yueh Tsai; Yi-Ru Lin
Journal:  Hum Brain Mapp       Date:  2014-10-23       Impact factor: 5.038

5.  Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis.

Authors:  Henrik Kahr Mathiesen; Thomas Tscherning; Per Soelberg Sorensen; Henrik B W Larsson; Egill Rostrup; Olaf B Paulson; Lars G Hanson
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

Review 6.  Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

Authors:  Hans Lassmann
Journal:  Exp Neurol       Date:  2009-10-17       Impact factor: 5.330

Review 7.  MR spectroscopy in multiple sclerosis.

Authors:  Nicola De Stefano; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

8.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

9.  Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.

Authors:  Carmen Tur; Claudia A M Wheeler-Kingshott; Daniel R Altmann; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2012-12-26       Impact factor: 5.038

10.  Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.

Authors:  Lukas Haider; Constantina Simeonidou; Günther Steinberger; Simon Hametner; Nikolaos Grigoriadis; Georgia Deretzi; Gabor G Kovacs; Alexandra Kutzelnigg; Hans Lassmann; Josa M Frischer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-04       Impact factor: 10.154

View more
  16 in total

1.  Age-related Brain Metabolic Changes up to Seventh Decade in Healthy Humans : Whole-brain Magnetic Resonance Spectroscopic Imaging Study.

Authors:  Helen Maghsudi; Martin Schütze; Andrew A Maudsley; Mete Dadak; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Clin Neuroradiol       Date:  2019-07-26       Impact factor: 3.649

2.  Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

Authors:  Kristin P O'Grady; Adrienne N Dula; Bailey D Lyttle; Lindsey M Thompson; Benjamin N Conrad; Bailey A Box; Lydia J McKeithan; Siddharama Pawate; Francesca Bagnato; Bennett A Landman; Paul Newhouse; Seth A Smith
Journal:  Mult Scler       Date:  2018-09-19       Impact factor: 6.312

Review 3.  Methodological consensus on clinical proton MRS of the brain: Review and recommendations.

Authors:  Martin Wilson; Ovidiu Andronesi; Peter B Barker; Robert Bartha; Alberto Bizzi; Patrick J Bolan; Kevin M Brindle; In-Young Choi; Cristina Cudalbu; Ulrike Dydak; Uzay E Emir; Ramon G Gonzalez; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Petra S Huppi; Ralph E Hurd; Kejal Kantarci; Risto A Kauppinen; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Małgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Paul G Mullins; James B Murdoch; Sarah J Nelson; Ralph Noeske; Gülin Öz; Julie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Eva-Maria Ratai; Nouha Salibi; Tom W J Scheenen; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Franklyn A Howe
Journal:  Magn Reson Med       Date:  2019-03-28       Impact factor: 4.668

4.  Atlas-based GABA mapping with 3D MEGA-MRSI: Cross-correlation to single-voxel MRS.

Authors:  Ruoyun E Ma; James B Murdoch; Wolfgang Bogner; Ovidiu Andronesi; Ulrike Dydak
Journal:  NMR Biomed       Date:  2020-02-20       Impact factor: 4.044

5.  Whole-Brain Metabolic Abnormalities Are Associated With Mobility in Older Adults With Multiple Sclerosis.

Authors:  Christina Mueller; Jessica F Baird; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2022-02-14       Impact factor: 3.919

6.  Fast 3D rosette spectroscopic imaging of neocortical abnormalities at 3 T: Assessment of spectral quality.

Authors:  Claudiu V Schirda; Tiejun Zhao; Victor E Yushmanov; Yoojin Lee; Gena R Ghearing; Frank S Lieberman; Ashok Panigrahy; Hoby P Hetherington; Jullie W Pan
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

7.  7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?

Authors:  Eva Heckova; Bernhard Strasser; Gilbert J Hangel; Michal Považan; Assunta Dal-Bianco; Paulus S Rommer; Petr Bednarik; Stephan Gruber; Fritz Leutmezer; Hans Lassmann; Siegfried Trattnig; Wolfgang Bogner
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

Review 8.  Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.

Authors:  Yuan Cao; Wei Diao; Fangfang Tian; Feifei Zhang; Laichang He; Xipeng Long; Fuqinq Zhou; Zhiyun Jia
Journal:  Neuropsychol Rev       Date:  2021-02-13       Impact factor: 7.444

Review 9.  Genetics of glutamate and its receptors in autism spectrum disorder.

Authors:  Sabah Nisar; Ajaz A Bhat; Tariq Masoodi; Sheema Hashem; Sabah Akhtar; Tayyiba Akbar Ali; Sara Amjad; Sanjeev Chawla; Puneet Bagga; Michael P Frenneaux; Ravinder Reddy; Khalid Fakhro; Mohammad Haris
Journal:  Mol Psychiatry       Date:  2022-03-16       Impact factor: 13.437

10.  Motion correction methods for MRS: experts' consensus recommendations.

Authors:  Ovidiu C Andronesi; Pallab K Bhattacharyya; Wolfgang Bogner; In-Young Choi; Aaron T Hess; Phil Lee; Ernesta M Meintjes; M Dylan Tisdall; Maxim Zaitzev; André van der Kouwe
Journal:  NMR Biomed       Date:  2020-07-20       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.